Is the G2019S LRRK2 mutation common in all southern European populations?

scientific article published on 9 July 2008

Is the G2019S LRRK2 mutation common in all southern European populations? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JOCN.2007.08.013
P698PubMed publication ID18617409

P2093author name stringCarlos Singer
Spiridon Papapetropoulos
Andreas A Argyriou
Elizabeth Chroni
Lina Shehadeh
Nanette Bishopric
Nikhil Adi
P433issue9
P1104number of pages4
P304page(s)1027-1030
P577publication date2008-07-09
P1433published inJournal of Clinical NeuroscienceQ6294963
P1476titleIs the G2019S LRRK2 mutation common in all southern European populations?
P478volume15

Reverse relations

cites work (P2860)
Q36188579Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations
Q46724331Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson’s disease in a Han-Chinese population in south-eastern China
Q44696634Genetic assessment of familial and early-onset Parkinson's disease in a Greek population
Q54786905LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity.
Q60047792Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease
Q38738200Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.
Q37597933The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews
Q52374337The Role of LRRK2 in Neurodegeneration of Parkinson Disease
Q34513714The genetic background of Parkinson's disease: current progress and future prospects

Search more.